{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:42:47Z","timestamp":1792788167005,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Research on prevention and control of major chronic noncommunicable diseases of China","award":["2016YFC1304603"],"award-info":[{"award-number":["2016YFC1304603"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>High incidence of deep vein thrombosis (DVT) has been observed in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 and those by bacterial pneumonia. However, the differences of incidence and risk factors of DVT in these two groups of ARDS had not been reported before.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study design and methods<\/jats:title>\n                    <jats:p>We performed a retrospective cohort study to investigate the difference of DVT in incidence and risk factors between the two independent cohorts of ARDS and eventually enrolled 240 patients, 105 of whom with ARDS caused by COVID-19 and 135 caused by bacterial pneumonia. Lower extremity venous compression ultrasound scanning was performed whenever possible regardless of clinical symptoms in the lower limbs. Clinical characteristics, including demographic information, clinical history, vital signs, laboratory findings, treatments, complications, and outcomes, were analyzed for patients with and without DVT in these two cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The 28-days incidence of DVT was higher in patients with COVID-19 than in those with bacterial pneumonia (57.1% vs 41.5%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.016). Taking death as a competitive risk, the Fine-Gray test showed no significant difference in the 28-day cumulative incidence of DVT between these two groups (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.220). Fine-Gray competing risk analysis also showed an association between increased CK (creatine kinase isoenzyme)-MB levels (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003), decreased PaO\n                      <jats:sub>2<\/jats:sub>\n                      (partial pressure of arterial oxygen)\/FiO\n                      <jats:sub>2<\/jats:sub>\n                      (fraction of inspired oxygen) ratios (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.081), increased D-dimer levels (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.064) and increased incidence of DVT in COVID-19 cohort, and an association between invasive mechanical ventilation (IMV;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001) and higher incidence of DVT and an association between VTE prophylaxis (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.007) and lower incidence of DVT in bacterial pneumonia cohort. The sensitivity and specificity of the corresponding receiver operating characteristic curve originating from the combination of CK-MB levels, PaO\n                      <jats:sub>2<\/jats:sub>\n                      \/FiO\n                      <jats:sub>2<\/jats:sub>\n                      ratios, and D-dimer levels \u22650.5\u2009\u03bcg\/mL were higher than that of the DVT Wells score (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.020) and were not inferior to that of the Padua prediction score (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.363) for assessing the risk of DVT in COVID-19 cohort.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The incidence of DVT in patients with ARDS caused by COVID-19 is higher than those caused by bacterial pneumonia. Furthermore, the risk factors for DVT are completely different between these two ARDS cohorts. It is suggested that COVID-19 is probably an additional risk factor for DVT in ARDS patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12959-022-00386-y","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T02:02:54Z","timestamp":1652148174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Comparison of deep vein thrombosis risks in acute respiratory distress syndrome caused by COVID-19 and bacterial pneumonia: a retrospective cohort study"],"prefix":"10.1186","volume":"20","author":[{"given":"Na","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunguo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenlu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokai","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"issue":"10063","key":"386_CR1","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1016\/S0140-6736(16)30514-1","volume":"388","author":"M Di Nisio","year":"2016","unstructured":"Di Nisio M, van Es N, B\u00fcller HR. Deep vein thrombosis and pulmonary embolism. Lancet. 2016;388(10063):3060\u201373.","journal-title":"Lancet."},{"issue":"10","key":"386_CR2","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1002\/jmv.23354","volume":"84","author":"M Goeijenbier","year":"2012","unstructured":"Goeijenbier M, van Wissen M, van de Weg C, et al. Review: viral infections and mechanisms of thrombosis and bleeding. J Med Virol. 2012;84(10):1680\u201396.","journal-title":"J Med Virol"},{"key":"386_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok FA, Kruip M, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145\u20137.","journal-title":"Thromb Res"},{"issue":"7","key":"386_CR4","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/ajh.25829","volume":"95","author":"E Terpos","year":"2020","unstructured":"Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834\u201347.","journal-title":"Am J Hematol"},{"issue":"5","key":"386_CR5","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1016\/S2352-3026(20)30109-5","volume":"7","author":"T Wang","year":"2020","unstructured":"Wang T, Chen R, Liu C, et al. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol. 2020;7(5):e362\u20133.","journal-title":"Lancet Haematol"},{"key":"386_CR6","doi-asserted-by":"crossref","unstructured":"Aljuhani O, Alsulaiman K, Hafiz A, et al. Comparison Between Standard Vs. Escalated Dose Venous Thromboembolism (VTE) Prophylaxis in Critically Ill Patients with COVID-19: A Two centers, Observational Study. Saudi Pharm J. 2022 Feb 3.","DOI":"10.21203\/rs.3.rs-486818\/v1"},{"issue":"12","key":"386_CR7","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1001\/jamainternmed.2021.6203","volume":"181","author":"AC Spyropoulos","year":"2021","unstructured":"Spyropoulos AC, Goldin M, Giannis D, et al. Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for Thromboprophylaxis in high-risk hospitalized patients with COVID-19: the HEP-COVID randomized clinical trial. JAMA Intern Med. 2021;181(12):1612\u201320.","journal-title":"JAMA Intern Med"},{"issue":"4","key":"386_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/1358863X21995566","volume":"26","author":"A Kollias","year":"2021","unstructured":"Kollias A, Kyriakoulis KG, Lagou S, et al. Venous thromboembolism in COVID-19: a systematic review and meta-analysis. Vasc Med. 2021;26(4):415\u201325.","journal-title":"Vasc Med"},{"issue":"2","key":"386_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.120.046702","volume":"142","author":"L Zhang","year":"2020","unstructured":"Zhang L, Feng X, Zhang D, et al. Deep vein thrombosis in hospitalized patients with COVID-19 in Wuhan, China: prevalence, risk factors, and outcome. Circulation. 2020;142(2):114\u201328.","journal-title":"Circulation."},{"issue":"1","key":"386_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12959-021-00325-3","volume":"19","author":"N Cui","year":"2021","unstructured":"Cui N, Jiang C, Chen H, Zhang L, Feng X. Prevalence, risk, and outcome of deep vein thrombosis in acute respiratory distress syndrome. Thromb J. 2021;19(1):71.","journal-title":"Thromb J"},{"issue":"5","key":"386_CR11","doi-asserted-by":"publisher","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","volume":"55","author":"C Zhang","year":"2020","unstructured":"Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020;55(5):105954.","journal-title":"Int J Antimicrob Agents"},{"key":"386_CR12","doi-asserted-by":"publisher","DOI":"10.15557\/PiMR.2020.0003","volume-title":"Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance,13 march 2020","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance,13 march 2020. Geneva: World Health Organization; 2020."},{"issue":"23","key":"386_CR13","first-page":"2526","volume":"307","author":"VM Ranieri","year":"2012","unstructured":"Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin definition. Jama. 2012;307(23):2526\u201333.","journal-title":"Jama."},{"key":"386_CR14","unstructured":"National Health Commission of the People\u2019s Republic of China. Chinese management guideline for COVID-19, version 6.0. http:\/\/www.nhc.gov.cn\/yzygj\/s7653p\/202002\/8334a8326dd94d329df351d7da8aefc2\/files\/b2."},{"issue":"5","key":"386_CR15","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, et al. Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61\u2013e111.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"386_CR16","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45\u201367.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"386_CR17","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","volume":"8","author":"S Barbar","year":"2010","unstructured":"Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua prediction score. J Thromb Haemost. 2010;8(11):2450\u20137.","journal-title":"J Thromb Haemost"},{"issue":"10","key":"386_CR18","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818\u201329.","journal-title":"Crit Care Med"},{"issue":"1","key":"386_CR19","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s13054-019-2663-7","volume":"23","author":"S Lambden","year":"2019","unstructured":"Lambden S, Laterre PF, Levy MM, Francois B. The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit Care. 2019;23(1):374.","journal-title":"Crit Care"},{"issue":"3","key":"386_CR20","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837\u201345.","journal-title":"Biometrics."},{"issue":"3","key":"386_CR21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jvsv.2018.08.010","volume":"7","author":"AT Obi","year":"2019","unstructured":"Obi AT, Tignanelli CJ, Jacobs BN, et al. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza a H1N1 acute respiratory distress syndrome patients. J Vasc Surg Venous Lymphat Disord. 2019;7(3):317\u201324.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"1","key":"386_CR22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12890-021-01632-1","volume":"21","author":"N Cui","year":"2021","unstructured":"Cui N, Mi S, Jiang C, et al. Deep vein thrombosis in acute respiratory distress syndrome caused by bacterial pneumonia. BMC Pulm Med. 2021;21(1):264.","journal-title":"BMC Pulm Med"},{"issue":"2","key":"386_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1161\/CIRCULATIONAHA.120.047407","volume":"142","author":"B Ren","year":"2020","unstructured":"Ren B, Yan F, Deng Z, et al. Extremely high incidence of lower extremity deep venous thrombosis in 48 patients with severe COVID-19 in Wuhan. Circulation. 2020;142(2):181\u20133.","journal-title":"Circulation."},{"issue":"34","key":"386_CR24","doi-asserted-by":"publisher","first-page":"12077","DOI":"10.1073\/pnas.0504526102","volume":"102","author":"A Hezi-Yamit","year":"2005","unstructured":"Hezi-Yamit A, Wong PW, Bien-Ly N, et al. Synergistic induction of tissue factor by coagulation factor Xa and TNF: evidence for involvement of negative regulatory signaling cascades. Proc Natl Acad Sci U S A. 2005;102(34):12077\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"386_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/jth.13194","volume":"14","author":"AH Schmaier","year":"2016","unstructured":"Schmaier AH. The contact activation and kallikrein\/kinin systems: pathophysiologic and physiologic activities. J Thromb Haemost. 2016;14(1):28\u201339.","journal-title":"J Thromb Haemost"},{"issue":"7","key":"386_CR26","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","volume":"5","author":"S Shi","year":"2020","unstructured":"Shi S, Qin M, Shen B, et al. Association of Cardiac Injury with Mortality in hospitalized patients with COVID-19 in Wuhan. China JAMA cardiology. 2020;5(7):802\u201310.","journal-title":"China JAMA cardiology"},{"issue":"7","key":"386_CR27","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1001\/jamacardio.2020.0934","volume":"5","author":"C Yang","year":"2020","unstructured":"Yang C, Jin Z. An acute respiratory infection runs into the Most common noncommunicable epidemic-COVID-19 and cardiovascular diseases. JAMA Cardiol. 2020;5(7):743\u20134.","journal-title":"JAMA Cardiol"},{"issue":"10235","key":"386_CR28","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/S0140-6736(20)30920-X","volume":"395","author":"H Li","year":"2020","unstructured":"Li H, Liu L, Zhang D, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet (London, England). 2020;395(10235):1517\u201320.","journal-title":"Lancet (London, England)"},{"issue":"9","key":"386_CR29","doi-asserted-by":"publisher","first-page":"629","DOI":"10.7326\/M20-0533","volume":"172","author":"H Zhang","year":"2020","unstructured":"Zhang H, Zhou P, Wei Y, et al. Histopathologic changes and SARS-CoV-2 Immunostaining in the lung of a patient with COVID-19. Ann Intern Med. 2020;172(9):629\u201332.","journal-title":"Ann Intern Med"},{"issue":"10223","key":"386_CR30","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5.","journal-title":"Lancet"},{"issue":"10223","key":"386_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u201313. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7.","journal-title":"Lancet."},{"issue":"10","key":"386_CR32","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1161\/CIRCRESAHA.120.317055","volume":"126","author":"A Akhmerov","year":"2020","unstructured":"Akhmerov A, Marb\u00e1n E. COVID-19 and the heart. Circ Res. 2020;126(10):1443\u201355.","journal-title":"Circ Res"},{"issue":"5","key":"386_CR33","first-page":"518","volume":"5","author":"D Atri","year":"2020","unstructured":"Atri D, Siddiqi HK, Lang JP, Nauffal V, Morrow DA, Bohula EA. COVID-19 for the cardiologist: basic virology, epidemiology, cardiac manifestations, and potential therapeutic strategies. JACC. Basic Transl Sci. 2020;5(5):518\u201336.","journal-title":"Basic Transl Sci"},{"issue":"6","key":"386_CR34","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/cvr\/cvaa078","volume":"116","author":"L Chen","year":"2020","unstructured":"Chen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020;116(6):1097\u2013100.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"386_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","volume":"17","author":"YY Zheng","year":"2020","unstructured":"Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259\u201360.","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"386_CR36","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s15010-020-01424-5","volume":"48","author":"JH Zeng","year":"2020","unstructured":"Zeng JH, Liu YX, Yuan J, et al. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection. 2020;48(5):773\u20137.","journal-title":"Infection."},{"key":"386_CR37","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijcard.2020.03.086","volume":"311","author":"E Ammirati","year":"2020","unstructured":"Ammirati E, Wang DW. SARS-CoV-2 inflames the heart. The importance of awareness of myocardial injury in COVID-19 patients. Int J Cardiol. 2020;311:122\u20133.","journal-title":"Int J Cardiol"},{"key":"386_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.thromres.2017.01.004","volume":"151","author":"TH Kuo","year":"2017","unstructured":"Kuo TH, Li HY, Lin SH. Acute kidney injury and risk of deep vein thrombosis and pulmonary embolism in Taiwan: a nationwide retrospective cohort study. Thromb Res. 2017;151:29\u201335.","journal-title":"Thromb Res"},{"issue":"9","key":"386_CR39","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1111\/jth.12652","volume":"12","author":"CF Christiansen","year":"2014","unstructured":"Christiansen CF, Schmidt M, Lamberg AL, et al. Kidney disease and risk of venous thromboembolism: a nationwide population-based case-control study. J Thromb Haemost. 2014;12(9):1449\u201354.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"386_CR40","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1160\/TH06-09-0513","volume":"97","author":"I Mah\u00e9","year":"2007","unstructured":"Mah\u00e9 I, Aghassarian M, Drouet L, et al. Tinzaparin and enoxaparin given at prophylactic dose for eight days in medical elderly patients with impaired renal function: a comparative pharmacokinetic study. Thromb Haemost. 2007;97(4):581\u20136.","journal-title":"Thromb Haemost"},{"issue":"10","key":"386_CR41","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1111\/j.1538-7836.2009.03556.x","volume":"7","author":"P Schmid","year":"2009","unstructured":"Schmid P, Brodmann D, Odermatt Y, Fischer AG, Wuillemin WA. Study of bioaccumulation of dalteparin at a therapeutic dose in patients with renal insufficiency. J Thromb Haemost. 2009;7(10):1629\u201332.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"386_CR42","doi-asserted-by":"publisher","first-page":"R32","DOI":"10.1186\/cc6810","volume":"12","author":"D Cook","year":"2008","unstructured":"Cook D, Douketis J, Meade M, et al. Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors. Crit Care. 2008;12(2):R32.","journal-title":"Crit Care"},{"issue":"10","key":"386_CR43","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1177\/0885066618813300","volume":"35","author":"CD Gibson","year":"2020","unstructured":"Gibson CD, Colvin MO, Park MJ, et al. Prevalence and predictors of deep vein thrombosis in critically ill medical patients who underwent diagnostic duplex ultrasonography. J Intensive Care Med. 2020;35(10):1062\u20136.","journal-title":"J Intensive Care Med"},{"issue":"5","key":"386_CR44","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1378\/chest.15-0287","volume":"148","author":"D Kaplan","year":"2015","unstructured":"Kaplan D, Casper TC, Elliott CG, et al. VTE incidence and risk factors in patients with severe Sepsis and septic shock. Chest. 2015;148(5):1224\u201330.","journal-title":"Chest."},{"issue":"23","key":"386_CR45","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1182\/blood.2020006000","volume":"135","author":"JM Connors","year":"2020","unstructured":"Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033\u201340.","journal-title":"Blood."},{"key":"386_CR46","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.3389\/fimmu.2019.02569","volume":"10","author":"N Beristain-Covarrubias","year":"2019","unstructured":"Beristain-Covarrubias N, Perez-Toledo M, Thomas MR, Henderson IR, Watson SP, Cunningham AF. Understanding infection-induced thrombosis: lessons learned from animal models. Front Immunol. 2019;10:2569.","journal-title":"Front Immunol"},{"key":"386_CR47","doi-asserted-by":"publisher","first-page":"124610","DOI":"10.5402\/2011\/124610","volume":"2011","author":"F Moheimani","year":"2011","unstructured":"Moheimani F, Jackson DE. Venous thromboembolism: classification, risk factors, diagnosis, and management. ISRN Hematol. 2011;2011:124610.","journal-title":"ISRN Hematol"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-022-00386-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-022-00386-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-022-00386-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T03:08:25Z","timestamp":1652152105000},"score":1,"resource":{"primary":{"URL":"https:\/\/thrombosisjournal.biomedcentral.com\/articles\/10.1186\/s12959-022-00386-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["386"],"URL":"https:\/\/doi.org\/10.1186\/s12959-022-00386-y","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,10]]},"assertion":[{"value":"22 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study involving human participants was approved by the Union Hospital, affiliated with Tongji Medical College, Huazhong University of Science and Technology (2020\u20130197), and the ethics committee of the Beijing Chao-Yang Hospital, Capital Medical University (2020-ke-429) and was conducted in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}